Deep Brain Stimulation ‍Offers‍ Hope for Parkinson’s mobility

⁣ Updated May 28, 2025

German researchers are exploring how deep brain stimulation can improve mobility for individuals with ‍Parkinson’s disease. The study, featured in Scientific Reports, investigates stimulating specific brain regions to enhance patients’ quality of life by improving their ambulatory ⁤ability. The research ⁢focuses on identifying new brain areas that could benefit from stimulation, ⁣offering potential therapeutic advancements for Parkinson’s patients.

Deep brain stimulation, sometimes called a “brain pacemaker,”⁤ involves⁢ implanting an electrical⁢ pulse emitter in the brain. This is frequently enough done in the subthalamic nucleus, a key part of the basal ganglia system.‍ When medication no longer effectively ⁢alleviates mobility restrictions⁢ in advanced Parkinson’s, this method can offer⁤ an ‍alternative.

Dr. ⁢Liana⁢ Melo-Thomas, from Philipps-Universität Marburg, previously ⁣demonstrated in rat studies that stimulating⁣ the ‍inferior colliculus, primarily known for auditory input processing, can overcome mobility limitations. Melo-Thomas said there are⁢ indications that stimulating this brain region activates ⁣the mesencephalic locomotor region ⁣(MLR).

Unlike the basal ganglia, the inferior colliculus remains unaffected by Parkinson’s disease. Melo-Thomas’s ‍research⁣ group ⁣discovered⁢ that⁤ stimulating this‍ area⁢ activates alternative motor pathways, possibly improving patient mobility. The⁢ current study further investigates⁤ the activating influence of the inferior colliculus on the MLR, with the expectation that it will positively ‍affect ambulatory ability.

to investigate further, Professor Rainer Schwarting’s Marburg ‍group collaborated with Dr. Wolfgang⁢ Kruse from Ruhr University Bochum, whose team, led by Professor Stefan Herlitze, helped co-develop optogenetics methods. This technique involves ⁣genetically modifying test animals so that nerve cells in⁣ specific brain regions produce⁤ a⁤ light-sensitive protein. By implanting small optical fibers,⁢ researchers can then use light to selectively activate or inhibit these cells.

Kruse‍ said this method is more‍ precise than electrical stimulation, wich affects the area surrounding the cells. The researchers directly documented the stimulation’s effect using electrophysiological measurements of neuronal activity in the target structures, ⁢employing a ⁢multi-electrode system developed at Philipps-Universität Marburg. This allowed ⁢them to directly understand the stimulation’s impact.Simultaneous measurements ⁢with up to four electrodes also minimized the number of animals used.

Optogenetic stimulation of ⁢the inferior colliculus primarily triggered the expected increase in neuronal activity. Kruse reported that⁣ simultaneous measurements ⁣in the deeper MLR region showed increased activity in moast cells, even though ⁢nearly a quarter⁤ of the cells were inhibited. the activation of ⁤individual nerve cells occurred with⁢ an ‍average delay of 4.7 milliseconds, indicating a functional synaptic interconnection between the inferior colliculus and MLR.

“Even if the ⁢path toward new therapeutic approaches to alleviating the symptoms⁢ of parkinson’s disease still‍ appears long, such foundational research is immensely crucial,” Kruse said.

What’s next

Further inquiry into the interconnections ‍between the inferior colliculus and the MLR‍ may provide new insights that could optimize deep brain⁤ stimulation therapy for Parkinson’s ⁢disease in the ⁤long term. Researchers⁢ aim to fully understand the mechanisms that ‍lead to symptom relief with deep brain stimulation in the ⁢basal ganglia.